000 01863 a2200505 4500
005 20250514215956.0
264 0 _c20051005
008 200510s 0 0 eng d
022 _a1527-9995
024 7 _a10.1016/j.urology.2004.09.041
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKong, Chuize
245 0 0 _aInhibition of tumor angiogenesis during cisplatin chemotherapy for bladder cancer improves treatment outcome.
_h[electronic resource]
260 _bUrology
_cFeb 2005
300 _a395-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAngiogenesis Inhibitors
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aAntibiotics, Antineoplastic
_xadministration & dosage
650 0 4 _aAntineoplastic Agents, Alkylating
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aApoptosis
650 0 4 _aCarcinoma, Transitional Cell
_xblood supply
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aCombined Modality Therapy
650 0 4 _aCyclohexanes
650 0 4 _aDrug Screening Assays, Antitumor
650 0 4 _aDrug Synergism
650 0 4 _aInjections, Intraperitoneal
650 0 4 _aMale
650 0 4 _aNeovascularization, Pathologic
_xdrug therapy
650 0 4 _aO-(Chloroacetylcarbamoyl)fumagillol
650 0 4 _aRandom Allocation
650 0 4 _aRats
650 0 4 _aSesquiterpenes
_xadministration & dosage
650 0 4 _aUrinary Bladder Neoplasms
_xblood supply
700 1 _aZhu, Yuyan
700 1 _aSun, Changcheng
700 1 _aLi, Zeliang
700 1 _aSun, Zhixi
700 1 _aZhang, Xianghua
700 1 _aTakanaka, Ikusama
773 0 _tUrology
_gvol. 65
_gno. 2
_gp. 395-9
856 4 0 _uhttps://doi.org/10.1016/j.urology.2004.09.041
_zAvailable from publisher's website
999 _c15384053
_d15384053